Strauch B
Štrauch, Branislav
VIAF ID: 85517562 (Personal)
Permalink: http://viaf.org/viaf/85517562
Preferred Forms
- 100 0 _ ‡a Strauch B
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Biochemical Testing After Pheochromocytoma Removal: How Early? | |
Changes in energy metabolism in pheochromocytoma. | |
Determination of doxazosin and verapamil in human serum by fast LC-MS/MS: application to document non-compliance of patients. | |
Development of a fast LC-MS/MS method for quantification of rilmenidine in human serum: elucidation of fragmentation pathways by HRMS. | |
Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. | |
Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension | |
High incidence of cardiovascular complications in pheochromocytoma. | |
Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. | |
Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? | |
Increased carotid intima-media thickness in patients with pheochromocytoma in comparison to essential hypertension. | |
Left ventricle remodeling in men with moderate to severe volume-dependent hypertension | |
Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness | |
Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism | |
Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. | |
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. | |
Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. | |
Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. | |
Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study | |
Should All Patients with Resistant Hypertension Receive Spironolactone? |